" class="no-js "lang="en-US"> Lord James Bethell - Medtech Alert
Thursday, March 30, 2023

Breaking News

Nanoscope Therapeutics Announces Positive Topline Results from Phase 2b RESTORE Trial of MCO-010 for the Treatment of Retinitis Pigmentosa Glyscend Therapeutics Appoints Biotech Industry Veteran Michael Wyzga to its Board of Directors Trobix Bio Raises $3 Million from Chartered Group to Advance Precision Microbiome Oncology Therapeutics Mathai Mammen to Join FogPharma as Chairman, President and Chief Executive Officer Confo Therapeutics Enters into Collaboration Agreement with Daiichi Sankyo to Discover Novel Medicines for CNS Diseases Implantica Launches RefluxStop™ in Italy Granular Therapeutics to Accelerate Development of Next-Generation Pipeline for Treating Mast Cell Driven Diseases Xeris Biopharma Appoints Ricki Fairley to Board of Directors AskBio to Present Phase 1b Results Investigating AB-1005 as Treatment for Parkinson’s Disease New Imaging Method for Evaluating Transport of Oxygen to Blood Cells
Lord James Bethell

Lord James Bethell

About Lord James Bethell

Lord Bethell of Romford was appointed as a Parliamentary Under Secretary of State at the Department of Health and Social Care on 9 March 2020. He was previously a Government Whip (Lord in Waiting) from July 2019 to March 2020.

As the House of Lords minister, he is responsible for representing all health matters and legislation in the Upper House. He is also the junior minister supporting the health track of the G7 summit.

Lord Bethell graduated from Edinburgh University with an MA(Hons). He worked as a journalist for national newspapers and then as a director of several media companies, including the Ministry of Sound. He sold his own communications firm in 2019.

Related Story

Cardiovascular

 Nationwide Roll-Out of NHS High Street Heart Checks to Save Thousands of Lives | Pharmtech Focus

Nationwide Roll-Out of NHS High Street Heart Checks to Save Thousands of Lives

August 24 2021

Thousands of lives will be saved thanks to more blood pressure checks in high street […]

News

 MHRA Puts Delivering for Patients at the Heart of its Delivery Plan 2021-2023 | Pharmtech Focus

MHRA Puts Delivering for Patients at the Heart of its Delivery Plan 2021-2023

July 5 2021

A new and ambitious Delivery Plan centred on putting patients first, has been published today […]

Clinical Trials

 £64 Million Funding to Back UK-wide Plan to Strengthen Clinical Research Delivery | Pharmtech Focus

£64 Million Funding to Back UK-wide Plan to Strengthen Clinical Research Delivery

June 24 2021

Better health outcomes through more effective and efficient research as seen throughout the pandemic Promoting […]

COVID-19

 Government and Life Science Industry Join Forces on 100 Days Mission for Future Pandemics | Pharmtech Focus

Government and Life Science Industry Join Forces on 100 Days Mission for Future Pandemics

June 4 2021

Life science industry leaders are joining forces with governments to step up collective efforts to […]

COVID-19

 Study into Whether Vaccination of Previously Infected Generates Stronger

Study into Whether Vaccination of Previously Infected Generates Stronger, Broader Coronavirus Antibody Response

May 26 2021

NHS Blood and Transplant (NHSBT) is carrying out a study in the Birmingham region aimed […]